Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 285: C823-C830, 2003. First published June 11, 2003; doi:10.1152/ajpcell.00053.2003
0363-6143/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/C823    most recent
00053.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roelen, B. A. J.
Right arrow Articles by Lin, H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roelen, B. A. J.
Right arrow Articles by Lin, H. Y.

RECEPTORS AND SIGNAL TRANSDUCTION

Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-{beta}-induced nuclear accumulation

Bernard A. J. Roelen,1,2,* Ori S. Cohen,1,2,* Malay K. Raychowdhury,2 Deborah N. Chadee,3 Ying Zhang,1,2 John M. Kyriakis,3 Alessandro A. Alessandrini,2 and Herbert Y. Lin1,2

1Program in Membrane Biology and 2Renal Unit, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Charlestown 02129; and 3Molecular Cardiology Research Institute, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111

Submitted 6 February 2003 ; accepted in final form 2 June 2003

Smad4, the common Smad, is central for transforming growth factor (TGF)-{beta} superfamily ligand signaling. Smad4 has been shown to be constitutively phosphorylated (Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin C-H, Miyazono K, and ten Dijke P. EMBO J 16: 5353-5362, 1997), but the site(s) of phosphorylation, the kinase(s) that performs this phosphorylation, and the significance of the phosphorylation of Smad4 are currently unknown. This report describes the identification of a consensus ERK phosphorylation site in the linker region of Smad4 at Thr276. Our data show that ERK can phosphorylate Smad4 in vitro but not Smad4 with mutated Thr276. Flag-tagged Smad4-T276A mutant protein accumulates less efficiently in the nucleus after stimulation by TGF-{beta} and is less efficient in generating a transcriptional response than Smad4 wild-type protein. Tryptic phosphopeptide mapping identified a phosphopeptide in Smad4 wild-type protein that was absent in phosphorylated Smad4-T276A mutant protein. Our results suggest that MAP kinase can phosphorylate Thr276 of Smad4 and that phosphorylation can lead to enhanced TGF-{beta}-induced nuclear accumulation and, as a consequence, enhanced transcriptional activity of Smad4.

signal transduction; mitogen-activated protein kinase; phosphopeptide mapping; extracellular signal-regulated kinase phosphorylation site; luciferase reporter



Address for reprint requests and other correspondence: H. Y. Lin, Renal Unit, Massachusetts General Hospital, and Dept. of Medicine, Harvard Medical School, 13th St. Bldg. 149, Charlestown, MA 02129 (E-mail: hlin{at}partners.org).




This article has been cited by other articles:


Home page
haematolHome page
G. Ramey, J.-C. Deschemin, and S. Vaulont
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes
Haematologica, June 1, 2009; 94(6): 765 - 772.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Suzuki, M. C. Wilkes, N. Garamszegi, M. Edens, and E. B. Leof
Transforming Growth Factor {beta} Signaling via Ras in Mesenchymal Cells Requires p21-Activated Kinase 2 for Extracellular Signal-Regulated Kinase-Dependent Transcriptional Responses
Cancer Res., April 15, 2007; 67(8): 3673 - 3682.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. Buck, M. Buchholz, M. Wagner, G. Adler, T. Gress, and V. Ellenrieder
The Tumor Suppressor KLF11 Mediates a Novel Mechanism in Transforming Growth Factor {beta}-Induced Growth Inhibition That Is Inactivated in Pancreatic Cancer
Mol. Cancer Res., November 1, 2006; 4(11): 861 - 872.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Liang, Y.-Y. Liang, K. Wrighton, D. Ungermannova, X.-P. Wang, F. C. Brunicardi, X. Liu, X.-H. Feng, and X. Lin
Ubiquitination and Proteolysis of Cancer-Derived Smad4 Mutants by SCFSkp2
Mol. Cell. Biol., September 1, 2004; 24(17): 7524 - 7537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.